Why Clinical Trials Fail Even When the Science Is Strong with Heather Grey, Senior Vice President and General Manager of Real World Data, Clinical Trials, and Registry at Omega Healthcare

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Clinical trials fail far more often due to flawed operations and unusable data than because of poor science. In this episode, Heather Grey, Senior Vice President and General Manager of Real World Data, Clinical Trials, and Registry at Omega Healthcare, explains why clinical research continues to stall despite scientific breakthroughs and growing excitement around AI. She details how messy data, underprepared sites, missed timelines, and gaps in education across patients, providers, and pharma create systemic delays that limit patient access and slow drug development. Heather shows how pairing clinical expertise with AI-driven data curation can produce FDA-grade data, keep trials on track, and enable more health systems to participate in research. She concludes by emphasizing that AI alone is insufficient, and that strong infrastructure, human quality assurance, and operational discipline are essential for expanding trial access and diversity. Tune in and learn how fixing execution, not chasing hype, is the real key to accelerating clinical trials! Resources: Connect with and follow Heather Grey on LinkedIn. Follow Omega Healthcare on LinkedIn and visit their website! Email Heather directly here.